Division of Endocrinology and Metabolism, Department of Internal Medicine, Taipei Medical University Hospital, Taiwan.
Comput Methods Programs Biomed. 2013 Aug;111(2):507-11. doi: 10.1016/j.cmpb.2013.05.006. Epub 2013 Jun 12.
COPD estimates the third leading cause of death by 2020. To reduce its complications becomes an important issue. The purpose of this study is to investigate the influenza vaccine effect for IHD occurrence with secondary to COPD. We used 11 years Taiwan National Health Insurance cohort research database and analyzed the relationships between vaccination and incident of IHD for COPD patients stratified by age. Total 29,178 COPD patients, 703 patients got vaccination out of 1464 who have developed IHD and 6010 patients vaccinated out of 27,714 that did not developed IHD. Major findings we observed: vaccination was associated with a reduced risk of IHD (OR, 0.746; 95% CI, 0.595-0.937) in elderly COPD patients. Influenza vaccination was associated with a reduced risk for IHD only in elderly COPD patients. Moreover, COPD patients with IHD had higher vaccination rate than without IHD.
COPD 预计将成为 2020 年的第三大死因。降低其并发症成为一个重要问题。本研究旨在探讨流感疫苗对继发于 COPD 的 IHD 发生的影响。我们使用了 11 年的台湾全民健康保险队列研究数据库,并分析了 COPD 患者中疫苗接种与 IHD 发生率之间的关系,按年龄分层。共有 29178 例 COPD 患者,其中 703 例发生了 IHD,1464 例中有 703 例接种了疫苗,27714 例未发生 IHD,其中 6010 例接种了疫苗。主要发现:在老年 COPD 患者中,疫苗接种与 IHD 风险降低相关(OR,0.746;95%CI,0.595-0.937)。流感疫苗接种仅与老年 COPD 患者的 IHD 风险降低相关。此外,患有 IHD 的 COPD 患者的疫苗接种率高于没有 IHD 的患者。